课题基金 / 基金详情

Studies to develop the prediction system for drug metabolism, pharmacokineties and toxicity.

Studies to develop the prediction system for drug metabolism, pharmacokineties and toxicity.
研究开发药物代谢、药代动力学和毒性的预测系统。
批准号:
15390172
负责人:
YOKOI Tsuyoshi
金额:
$8.45万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2005

项目摘要

项目成果

YOKOI Tsuyoshi的其他基金

相似基金

相关文献

中文摘要
翻译
我们利用大鼠药物反应芯片研究了肝毒性化学物质给药与基因表达谱之间的关系。从典型的肝毒性大鼠中分离肝脏mRNA,并进行含有1,097个药物反应基因的DMA芯片。所有测试的化学物质都产生了一种特定的基因表达模式。APAP与其他化学物质的聚类不同。从血清生化标记谱中,我们确定了10个上调基因和10个下调基因作为肝毒性的潜在标记。通过QT聚类,我们确定了每种化学物质的主要上调和下调表达模式。有趣的是,这些表达模式与生化标记谱的表达模式具有良好的相关性。总之,我们鉴定出了20种潜在毒性标记物,化学物质给药的表达谱分析可以推测出与毒性水平无关的毒性时间点,而且这种表达谱分析也可以作为检测潜在肝毒性的工具之一。我们采用典型肝毒性药物硫代乙酰胺(TA),构建肝毒性模型大鼠,同时测定基因表达谱,并寻找剂量与时间的相关性。给药后血清AST和ALT呈剂量依赖性升高,并在24小时达到最大值。各剂量组的分层聚类分析显示2个主要聚类。此外,各剂量组的分层聚类分析显示与所有剂量组相同的模式。此外,QT聚类分析获得的基因表达多数与TA毒性最大时间点相同。我们以前的研究中选择的个体基因表达谱与它们的剂量无关。这些发现表明,在没有发生毒性的情况下,潜在的毒性作用与它们的剂量无关,遵循特定基因表达谱和一般基因表达谱可以作为毒性的敏感标志。少
英文摘要
We investigated whether there is relationship in gene expression profiles of hepatotoxic chemicals administration by using Rat Drug Response Chip. Liver mRNA was isolated from the typical hepatotoxicant-administered rats and performed DMA microarray containing 1,097 drug response genes. All the tested chemicals generated a specific gene expression patterns. APAP was sorted different cluster from other chemicals. From serum biochemical markers profiles, we identified up-regulated 10 genes and down-regulated 10 genes as a potential marker of hepatotoxicity. By using QT clustering, we identified major up-regulated and down-regulated expression patterns from each chemical. Interestingly, these means of expression patterns had good correlation with expression patterns from biochemical markers profiles. In conclusion, we identified 20 potential toxicity markers and expression profile analysis of chemicals administration can guess toxic time point with independent of toxicity level and using … More this expression profile analysis was also available to be one of the tools of detecting potential hepatotoxicant.We used typical hepatotoxicant thioacetamide (TA), constructed liver toxicity model rats to perform simultaneous measurement of gene expression profiles and to find correlation between dosage and time. Serum AST and ALT were increased by TA administration with dose dependent manner and reached the maximal value at 24 hours. Hierarchical clustering analysis of all dosage groups showed 2 major clusters. Moreover, hierarchical clustering analysis of each dosage group showed the same pattern as shown in all dosage groups. Furthermore, gene expression majority obtained by QT clustering analysis had the same maximal time point of TA toxicity. Individual gene expression profiles selected our previous studies were independent on their dosage. These finding suggest that potential toxic effects in the absense of the occurrence of toxicity are independent on their dosage, and following specific gene expression profiles and general gene expression profiles can be a sensitive marker of toxicity. Less
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
Effects of histonedeacetylation and DNA methylationonconstitutive and TCDD-inducible expressions of human CYP1 family in MCF-7 and HeLa cells
组蛋白脱乙酰化和 DNA 甲基化对 MCF-7 和 HeLa 细胞中人 CYP1 家族组成型和 TCDD 诱导表达的影响
DOI: --
发表时间: 2003
期刊: Toxicological Letters 144(2)
影响因子: --
作者: [Nakajima, M.et al.]
通讯作者: M.et al.
Critical enhancer region to which AhR/ARNT and Sp1 bind in hurCYP1B1 gene.
hurCYP1B1 基因中 AhR/ARNT 和 Sp1 结合的关键增强子区域。
DOI: --
发表时间: 2003
期刊: Journal of Biochemistry 133(5)
影响因子: --
作者: [Tsuchiya, Y.et al.]
通讯作者: Y.et al.
Identification of autoantibody to aldolase B in sera from patients with troglitazone-induced liver disfunction.
曲格列酮引起的肝功能障碍患者血清中醛缩酶 B 自身抗体的鉴定。
DOI: --
发表时间: 2005
期刊: Toxicology 216
影响因子: --
作者: [Rawiwan Maniratanachote et al.]
通讯作者: Rawiwan Maniratanachote et al.
A novel polymorphism of human CYP2A6 gene, CYP2A6^*17, has an amino acid substitution(V365M) that reduces enzymatic activity.
人类 CYP2A6 基因的一种新多态性 CYP2A6^*17 具有降低酶活性的氨基酸取代 (V365M)。
DOI: --
发表时间: 2004
期刊: Clinical Pharmaceutical Therapeutics 76
影响因子: --
作者: [Rawiwan Maniratanachote et al., Yusuke Hara et al., Kei Takemoto et al., Tatsuki Fukami et al.]
通讯作者: Tatsuki Fukami et al.
6
    Establishment of drug hypersensitivity animal model and investigation of the mechanism.
    MicroRNAs as biomarkers for drug-induced liver injury
    • 批准号:
      21390174
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.4万
    • 财政年份:
      2009
    • 负责人:
      YOKOI Tsuyoshi
    • 依托单位:
    Role of microRNA on drug-induced hepatotoxocity
    • 批准号:
      18390049
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.35万
    • 财政年份:
      2006
    • 负责人:
      YOKOI Tsuyoshi
    • 依托单位:
    Investigation and evaluation of genetic polymorphisms of drug metabolizing
    • 批准号:
      12470523
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $7.49万
    • 财政年份:
      2000
    • 负责人:
      YOKOI Tsuyoshi
    • 依托单位:
    海外基金